Chemomab Therapeutics Ltd. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Chemomab Therapeutics Ltd. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $2.00K.
- Chemomab Therapeutics Ltd. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $32.00K.
- Chemomab Therapeutics Ltd. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $29.00K.
- Chemomab Therapeutics Ltd. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $562.00K.
- Chemomab Therapeutics Ltd. stock issued during period, value, stock options exercised for fiscal 2018 was $6.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $12.00K 20-F · filed 2026-03-23 | |
| 2025-06-30 | $2.00K 6-K · filed 2025-08-14 | |
| 2022-12-31 | $143.00K 20-F · filed 2025-04-04 | |
| 2022-09-30 | $32.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $29.00K 6-K · filed 2023-08-14 | |
| 2021-12-31 | $10.00K 20-F · filed 2024-03-28 | |
| 2020-09-30 | $562.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $125.00K 10-Q · filed 2021-11-12 | |
| 2018-12-31 | $6.00K 10-K · filed 2020-03-17 |